ALLMedicine™ Diabetic Ketoacidosis Center

May 15th, 2021 - To evaluate what factors determine utilization patterns and outcomes of continuous subcutaneous insulin infusion (CSII) in young adults with type 1 diabetes (T1D). Utilizing the Optum® de-identified Electronic Health Record (EHR) dataset between 2...

May 12th, 2021 - Delayed treatment for new-onset diabetes type 1 (T1D) can lead to diabetic ketoacidosis (DKA) with potentially devastating consequences. This prospective observational study aimed to characterize pediatric patients with DKA at hospital admission, ...

May 11th, 2021 - Diabetic ketoacidosis (DKA) is a known complication of patients with type 1 diabetes mellitus (T1DM), but less common in type 2 diabetes mellitus (T2DM). The aim of this study was to compare the outcomes of patients admitted to the hospital with D...

May 10th, 2021 - Managing Diabetic Ketoacidosis in Children.|2021|Tzimenatos L,Nigrovic LE,|

May 10th, 2021 - Insulin pumps, continuous glucose monitors (CGMs), and hybrid closed-loop insulin pumps with CGMs are available for the management of type 1 diabetes in patients of all ages and type 2 diabetes in patients treated with multiple daily injections of...

Sep 16th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Aug 10th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

Apr 10th, 2018 - The biochemical criteria for the diagnosis of diabetic ketoacidosis (DKA) are: Hyperglycemia (blood glucose >11 mmol/L [≈200 mg/dL]) Venous pH <7. 3 or serum bicarbonate <15 mmol/L Ketonemia (blood ß-hydroxybuyrate ≥3 mmol/L) or moderate or large k.

Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...

May 15th, 2021 - To evaluate what factors determine utilization patterns and outcomes of continuous subcutaneous insulin infusion (CSII) in young adults with type 1 diabetes (T1D). Utilizing the Optum® de-identified Electronic Health Record (EHR) dataset between 2...

May 12th, 2021 - Delayed treatment for new-onset diabetes type 1 (T1D) can lead to diabetic ketoacidosis (DKA) with potentially devastating consequences. This prospective observational study aimed to characterize pediatric patients with DKA at hospital admission, ...

May 11th, 2021 - Diabetic ketoacidosis (DKA) is a known complication of patients with type 1 diabetes mellitus (T1DM), but less common in type 2 diabetes mellitus (T2DM). The aim of this study was to compare the outcomes of patients admitted to the hospital with D...

May 10th, 2021 - Managing Diabetic Ketoacidosis in Children.|2021|Tzimenatos L,Nigrovic LE,|

Apr 29th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The majority of children with type 1 diabetes who tested positive for SARS-CoV-2 were cared for at home and did well, according to the first repor...

Mar 22nd, 2021 - About one in five people with type 1 diabetes in the United States hospitalized with diabetic ketoacidosis (DKA) is readmitted within 30 days, new research shows. The results from the National Readmission Database also show that deaths are higher ...

Mar 18th, 2021 - An increase in the use of insulin pumps and continuous glucose monitoring (CGM) around the world is benefiting children with type 1 diabetes, new research finds. An analysis of data for more than 25,000 participants aged 18 years or younger with t...

Mar 9th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The clinical course and prognosis of individuals hospitalized with diabetic ketoacidosis (DKA) are considerably worse among those who have COVID-1...

Jan 17th, 2021 - Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors during acute COVID-19 illness raises the risk for euglycemic diabetic ketoacidosis (euDKA), a new case series suggests. Five patients with type 2 diabetes who were taking SGLT2 inhibitors pr...